TAI · 6861.TW
InnoCare Optoelectronics Corporation
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
Loading market information…
TWO · 4175.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:21 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
MedFirst Healthcare Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 20.26% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
MedFirst Healthcare Services, Inc.’s forward annual dividend is NT$3.00 per share, paid annual. The forward yield is 6.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
MedFirst Healthcare Services, Inc.’s next earnings report is currently expected on Nov 17, 2026, with estimated earnings per share of NT$1.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow MedFirst Healthcare Services, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MedFirst Healthcare Services, Inc., established in 1990 and headquartered in Taoyuan City, Taiwan, is a prominent distributor of medical supplies throughout Taiwan and China. The company's diverse product range includes diabetes management items, respiratory treatment solutions, incontinence and wound care products, various medical devices, ostomy support systems, and pain relief remedies. It also provides nutritional supplements, rehabilitation aids, and products for homecare, childcare, and maternal health. Beyond medical necessities, MedFirst offers general wellness and lifestyle goods, such as beauty products, cosmetics, and health-conscious food and beverages. In addition to its sales through retail outlets and an online platform, the firm serves as a contractor for hospital medical supply departments, acts as an agent for international medical brands, and engages in the trade of water ionizers. Its comprehensive services extend to laundry provisions and prescription drug dispensing. Furthermore, MedFirst is involved in the management of shopping complexes located within hospitals.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2024 |
|---|
| Mar 11, 2025 |
| NT$1.41 |
| NT$2.05B |
| Q3 2024 | Nov 7, 2024 | NT$0.48 | NT$1.91B |
|---|
| Q2 2024 | Aug 8, 2024 | -NT$0.19 | NT$1.94B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
NT$28.40-NT$0.70 (-2.41%)
Applied BioCode Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.97% below the high.
NT$5.22-NT$0.26 (-4.74%)
Medtecs International Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
NT$21.30-NT$0.15 (-0.7%)
GlycoNex Incorporation’s quoted price sits in the lower half of its reported 52-week range, 29.0% below the high.
NT$23.35-NT$0.55 (-2.3%)
Wellell Inc.’s quoted price sits in the lower half of its reported 52-week range, 9.85% below the high.
NT$43.30-NT$0.30 (-0.69%)
HeXun Biosciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.53% below the high.
NT$54.70+NT$0.40 (+0.74%)
Dynamic Medical Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.79% below the high.
NT$72.10-NT$0.40 (-0.55%)
Crystalvue Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.45% below the high.
